Adjuvant icotinib versus observation in patients with completely resected EGFR-mutated stage IB NSCLC (GASTO1003, CORIN): a randomised, open-label, phase 2 trial
- Resource Type
- Article
- Source
- In
eClinicalMedicine March 2023 57 - Subject
- Language
- ISSN
- 2589-5370